JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection
published in: Gastroenterology
date of publication: 2020-04-25
Cites articles
There is nothing here
Article - wd:Q94446485